Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00691600 · ClinicalTrials.gov registry record · Phase 3
Management of Skin and Soft Tissue Abscesses in Pediatric Patients After Incision and Drainage
A Phase 3 study of Abscess, sponsored by Baylor College of Medicine.
- Completed
- Registry status
- Phase 3
- Development phase
- 23
- Enrollment target
- 1
- Study location
NCT00691600: Completed Phase 3 study of Abscess, sponsored by Baylor College of Medicine.
NCT00691600 is a Phase 3 study of Abscess that has completed, run by Baylor College of Medicine. The registered enrollment target is 23 participants, below the 388-participant average among 13 other Abscess trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00691600, a Phase 3 study of Abscess, has completed, sponsored by Baylor College of Medicine.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 23 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of the study is to compare rates of cure of abscesses with and without antibiotic treatment after incision and drainage. The purpose of this study is to compare successful rates of cure of abscesses less than 5 cm with antibiotic (oral TMP/SMX) versus non-antibiotic treatment after incision and drainage.
Primary Outcome
Outcomes will be measured by resolution of size, tenderness, and induration with erythema by parental report 7 - 10 days after initial visit to the Emergency Center
Conditions Studied
Interventions
- DRUG Placebo
- DRUG oral trimethoprim/sulfamethoxazole
Study Locations (1)
Texas
- Texas Children's Hospital - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 23 participants |
| Start Date | 2007-12 |
| Est. Completion | 2010-04 |
| Phase | Phase 3 |
What the finished NCT00691600 record still lists
NCT00691600 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 23 participants, a relatively small participant target, below the 388-participant average among 13 other Abscess trials with a reported enrollment target (94% lower).
The record links to 1 condition, with Abscess appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT00691600 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT00691600 about?
NCT00691600 is a clinical study titled "Management of Skin and Soft Tissue Abscesses in Pediatric Patients After Incision and Drainage". The purpose of the study is to compare rates of cure of abscesses with and without antibiotic treatment after incision and drainage. The purpose of this study is to compare successful rates of cure of abscesses less than 5 cm with antibiotic (oral TMP/SMX) versus non-antibiotic treatment after incis...
What is the current status of trial NCT00691600?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 23 participants. The study started on 2007-12. Estimated completion is 2010-04.
What conditions does trial NCT00691600 study?
This clinical trial studies the following conditions: Abscess.
What interventions are being tested in trial NCT00691600?
The interventions under investigation include: Placebo (DRUG), oral trimethoprim/sulfamethoxazole (DRUG).
Who is sponsoring clinical trial NCT00691600?
This trial is sponsored by Baylor College of Medicine, which has 616 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00691600 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Abscess
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00691600's enrollment target sits among peer trials
23 12th of 13 higher than 2 of 13 other Abscess trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Abscess trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Efficacy of Intranasal Fentanyl at Reducing Pain During Abscess Incision and Drainage (I&D) in Children
COMPLETED · Phase 3
-
Oritavancin Versus IV Vancomycin for the Treatment of Patients With Acute Bacterial Skin and Skin Structure Infection
COMPLETED · Phase 3
-
Efficacy and Safety of Dalbavancin for the Treatment of Acute Bacterial Skin and Skin Structure Infections
COMPLETED · Phase 3
-
Incision and Drainage Versus Needle Aspiration in Soft Tissue Abscesses
COMPLETED · Phase 3
-
Oritavancin Versus IV Vancomycin for the Treatment of Participants With Acute Bacterial Skin and Skin Structure Infection (SOLO I)
COMPLETED · Phase 3
-
Intranasal Fentanyl as an Adjunct to Lidocaine Infiltration in Adults Undergoing Abscess Incision and Drainage
COMPLETED · Phase 3
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03616041 · 23 participants
Capsule Endoscopy for Severe Hematochezia
- NCT04348747 · 23 participants · Phase 2
Dendritic Cell Vaccines Against Her2/Her3 and Pembrolizumab for the Treatment of Brain Metastasis From Triple Negative Breast Cancer or HER2+ Breast Cancer
- NCT04587687 · 23 participants · Phase 2
Brentuximab Vedotin and Bendamustine for the Treatment of Relapsed or Refractory Follicular Lymphoma
- NCT04715022 · 23 participants · Phase 1
Sympathetic-vascular Dysfunction in Obesity and Insulin Resistance (Vitamin C Study)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia